Hansa Biopharma on 2nd October announced the raise of approximately USD 71 million through directed share issue

Hansa Biopharma on 2^nd October announced the raise of approximately USD 71 million through directed share issue, with strong support from new shareholders such as Polar Capital LLP, as well as existing shareholders.